Zachary D Crees

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 5

Top Topics

Endoplasmic Reticulum Stress

Multiple Myeloma

Hematopoietic Stem Cell

Hodgkin Lymphoma

Top Venues

Nature medicine

Future oncology (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Zachary D Crees, Michael P Rettig, Reyka G Jayasinghe, Keith E Stockerl-Goldstein, Sarah M Larson, Illes Arpad, Giulio A Milone, Massimo Martino, Patrick Joseph Stiff, Douglas Sborov, Denise Pereira, Ivana Micallef, Gemma Moreno-Jiménez, Gábor Mikala, Maria Liz Paciello Coronel, Udo Holtick, John Hiemenz, Muzaffar H Qazilbash, Nancy Hardy, Tahir Latif, Irene García-Cadenas, Abi Vainstein-Haras, Ella Sorani, Irit Gliko-Kabir, Inbal Goldstein, Debby Ickowicz, Liron Shemesh-Darvish, Shaul Kadosh, Feng Gao, Mark G Frattini, Ravi Vij, John F Dipersio
Motixafortide and G-CSF to mobilize hematopoietic stem cells for autologous transplantation in multiple myeloma: a randomized phase 3 trial. Nature medicine (2023)
Zachary D Crees, Michael P Rettig, Asad Bashey, Steven M Devine, Samantha M Jaglowski, Fei Wan, Amy Zhou, Melinda Harding, Abi Vainstein-Haras, Ella Sorani, Irit Gliko-Kabir, Brenda J Grossman, Peter Westervelt, John F DiPersio, Geoffrey L Uy
Hematopoietic Stem Cell Mobilization for Allogeneic Stem Cell Transplantation by Motixafortide, a Novel CXCR4 Inhibitor. Blood advances (2023)
Zachary D Crees, Michael P Rettig, John F Dipersio
Innovations in hematopoietic stem-cell mobilization: a review of the novel CXCR4 inhibitor motixafortide. Therapeutic advances in hematology 14 (2023)
Zachary D Crees, Armin Ghobadi
Cellular Therapy Updates in B-Cell Lymphoma: The State of the CAR-T. Cancers 13 (20) (2021)
Zachary D Crees, Keith Stockerl-Goldstein, Abi Vainstein, Hemda Chen, John F DiPersio
GENESIS: Phase III trial evaluating BL-8040 + G-CSF to mobilize hematopoietic cells for autologous transplant in myeloma. Future oncology (London, England) 15 (31) (2019)